Kang Kai, Wang Qianqian, Li Yujie, Liu Changxing, Yu Haozhen, Li Ning
Department of Traditional Chinese Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
First Clinical Medical School, Heilongjiang University of Chinese Medicine, Harbin, 150040, China.
BMC Cardiovasc Disord. 2025 Jul 15;25(1):510. doi: 10.1186/s12872-025-04954-8.
Heart failure (HF) is a growing global health issue, contributing to significant disease burden and increased mortality. The Global Burden of Disease (GBD) study offers comprehensive data on HF trends by age, sex, and region.
This study aimed to analyze trends in prevalence and years lived with disability (YLDs) of HF in China and globally from 1990 to 2021 based on GBD 2021 data.
A retrospective analysis using GBD 2021 data was conducted, covering HF burden in 204 countries from 1990 to 2021. Data were analyzed using Joinpoint regression and stratified by age and sex.
Global HF prevalence increased from 25.43 million in 1990 to 55.50 million in 2021, with an estimated annual percentage change (EAPC) of 2.50%. YLDs rose from 2.42 million to 5.31 million. In China, the EAPC for HF prevalence was 3.18%, surpassing the global rate. Males exhibited higher HF burden than females, and the disease burden rose sharply in those aged 65 and older.
Both global and Chinese HF burdens increased from 1990 to 2021, with China experiencing faster growth. Key public health recommendations include improving early screening, promoting lifestyle interventions, enhancing healthcare access, and integrating new therapies for heart failure.
心力衰竭(HF)是一个日益严重的全球健康问题,造成了重大的疾病负担并增加了死亡率。全球疾病负担(GBD)研究提供了按年龄、性别和地区划分的心力衰竭趋势的全面数据。
本研究旨在基于GBD 2021数据,分析1990年至2021年中国和全球心力衰竭患病率及伤残调整生命年(YLDs)的趋势。
使用GBD 2021数据进行回顾性分析,涵盖1990年至2021年204个国家的心力衰竭负担。数据采用Joinpoint回归分析,并按年龄和性别分层。
全球心力衰竭患病率从1990年的2543万增加到2021年的5550万,估计年变化百分比(EAPC)为2.50%。伤残调整生命年从242万增加到531万。在中国,心力衰竭患病率的EAPC为3.18%,超过全球水平。男性的心力衰竭负担高于女性,65岁及以上人群的疾病负担急剧上升。
1990年至2021年,全球和中国的心力衰竭负担均有所增加,中国增长更快。关键的公共卫生建议包括改善早期筛查、促进生活方式干预、增加医疗服务可及性以及整合心力衰竭新疗法。